XOMA Royalty (XOMA) Change in Taxes (2017 - 2022)

XOMA Royalty (XOMA) reported Change in Taxes of -$91000.0 for Q1 2022, up 94.54% sequentially from -$1.7 million in Q2 2018.

XOMA Royalty (XOMA) Change in Taxes (2017 - 2022) Analysis & Trends

XOMA Royalty (XOMA) has 3 years of Change in Taxes data on file, last reported at -$91000.0 in Q1 2022.

For the quarter ending Q1 2022, Change in Taxes changed N/A year-over-year to -$91000.0; the trailing twelve-month figure through Dec 2022 stood at -$91000.0 (changed N/A YoY), and the FY2022 full-year result was -$91000.0, down 200.0% from the prior year.
Change in Taxes improved to -$91000.0 in Q1 2022, from -$1.7 million in the prior quarter.
In the past five years, Change in Taxes ranged from a high of $29000.0 in Q1 2018 to a low of -$1.7 million in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-8,939.03
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	XOMA Royalty	478.42 Mn	412.34 Mn	-	-

Download Data